Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA)
- 31 January 1995
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 51 (1) , 25-31
- https://doi.org/10.1016/0010-7824(94)00007-j
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancerContraception, 1992
- Oral contraceptives and cervical neoplasiaContraception, 1991
- Injectable contraceptives and risk of invasive cervical cancer: Evidence of an associationInternational Journal of Cancer, 1990
- Association of oral contraceptive use and human papillomaviruses in invasive cervical cancersInternational Journal of Cancer, 1990
- Breast cancer and combined oral contraceptives: results from a multinational studyBritish Journal of Cancer, 1990
- RISK ASSESSMENT FOR CASE-CONTROL SUBGROUPS BY POLYCHOTOMOUS LOGISTIC REGRESSIONAmerican Journal of Epidemiology, 1986
- Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulvaGynecologic Oncology, 1983
- Detection of Herpesvirus Type-Specific Antibody by a Micro Solid Phase Radioimmunometric AssayIntervirology, 1979
- Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptivesAmerican Journal of Obstetrics and Gynecology, 1974
- Effects of depo-medroxyprogesterone acetate as a contraceptive agentAmerican Journal of Obstetrics and Gynecology, 1971